International Conference on

Cell Science & Molecular Biology

November 04-05, 2024 | Rome, Italy

Theme : Emerging Technologies in Single-Cell Analysis
Venue: Hampton By Hilton Rome North Fiano Romano

Organizing Committee

Check out our OCM

Submit Abstract

Submit Research Article

Early Bird Registration

Expiring on June 30, 2024

Download Brochure Now

About Cell Science & Molecular Biology

Stripe Conferences is delighted to extend our invitation and is honored to welcome you to the “ International Conference on Cell Science & Molecular Biology” event, taking place on November 04-05, 2024 in the beautiful city of Rome, Italy. This Cell Science Conferences is centred around the compelling theme of ”Emerging Technologies in Single-Cell Analysis.”

Join us for an enlightening exploration of the latest advancements in cell science and molecular biology at the Cell Science & Molecular Biology event by Stripe Conferences. Set against the picturesque backdrop of Rome, Italy on November 04-05, 2024 , focuses on “Emerging Technologies in Single-Cell Analysis.” Engage with leading experts, delve into cutting-edge research, and be part of shaping the future of scientific inquiry in this dynamic field. Reserve your place now for an unforgettable experience.


LaBarbera Daniel

University of Colorado AMC, UK.


Drexel University College of Medicine, US

Baobing Zhao

Shandong University, China

Nikolaos Trasanidis

Imperial College, UK

Scientific Sessions

01. Cell Biology and Molecular Biology

02. Single-cell sequencing

03. Epigenetics

04. Immunotherapy

05. 3D cell culture

06. Cell imaging and microscopy

07. Stem cell biology

08. Gene Therapy

Who to attend Cell Science Conferences?

Why to attend Cell Science Conferences?

Venue on Rome

Rome, the eternal city, resonates with a rich tapestry of history, culture, and art. As the epicenter of the ancient Roman Empire, it boasts majestic ruins like the Colosseum and the Roman Forum, bearing witness to its glorious past. The Vatican City, nestled within Rome, serves as the spiritual center of Catholicism, housing architectural wonders like St. Peter’s Basilica and the Sistine Chapel. Its labyrinthine streets lead to charming piazzas, bustling markets, and inviting cafes, each corner steeped in tradition and charm. Yet, Rome is not merely a relic of antiquity; it pulsates with modern life. Renowned for its culinary delights and vibrant nightlife, the city exudes a dynamic energy that captivates visitors.

From the grandeur of its historic landmarks to the warmth of its people, Rome remains a timeless destination, where the echoes of the past harmonize with the rhythms of the present, leaving an enduring impression on all who tread its storied streets.

General Surgery Cancer Conference

Media Partners & Collaborations

Event Summary

Conferences serve as essential platforms for academic researchers and business executives alike. They encompass various elements, including numerous presentations, interactive breakout sessions, hands-on product demonstrations, and unparalleled networking opportunities.

We’ve extended invitations to globally renowned keynote speakers, experts, brand ambassadors, and industry leaders, who will graciously share their insights and ideas with our esteemed conference attendees.

Payment for Stripe conferences registrations can only be made by credit card or debit card online and the listed payment applications.Cell Science Conferences

Why attend Cell Science ConferencesStripe Conferences? The answer is simple – to gain valuable insights into the challenges and opportunities in signal generation, transduction efficiency, and integration of transducers with biosensor platforms. These Stripe Conferences provide a platform where experts in the field share their knowledge and expertise, allowing attendees to learn from industry leaders. Not only do biosensors offer a way to monitor various processes indirectly, but attending International conferences also provides a unique networking opportunity. By connecting with like-minded professionals, you can expand your professional network and potentially collaborate on future projects. Moreover, Cell Science and Molecular Biology help you stay up-to-date with the latest trends and developments in your industry. With technology constantly evolving, attending these conferences ensures that you are always aware of the latest advances in the field of biosensors. So why miss out on such a valuable opportunity? Attend biosensors conferences and stay at the forefront of your industry.

The Stripe Conferences is organized by the Stripe journal Cell Science & Molecular Biology will take place virtually on November 04-05 2024 in Rome, Italy. Conferences Scientific Sessions list : 

    • Cell Biology and Molecular Biology
    • Single-cell sequencing
    • Epigenetics
    • Immunotherapy
    • 3D cell culture
    • Cell imaging and microscopy
    • Stem cell biology
    • Gene Therapy
    • Cellular Metabolism
    • Gene Expression
    • DNA Replication and Repair
    • Proteomics and Protein Structure

Welcome to the Stripe Conferences on the Future of Cell Science & Molecular Biology, which will be held on November 04-05 2024 in Rome, Italy.

Join us at Stripe Conferences for Cell Science Conferences 2024. Download the brochure to access essential information on speakers, guidelines, and the tentative program for this exciting event.

Media Partners & Collaborations

Upcoming Conferences 2024

Contact Us

If you ever need assistance or have questions, please don’t hesitate to reach out to our dedicated support team.
Call Back Request

WhatsApp Now

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”

LaBarbera Daniel

University of Colorado AMC, UK.

Dr. LaBarbera is the founding Director of the Center for Drug Discovery (CDD) established in 2020. The mission of the CDD is to lead a Colorado-wide drug discovery “grassroots” initiative based at CU AMC while encompassing other academic institutions and industries in Colorado. The CDD’s objectives are to facilitate drug discovery and development and become a central hub for drug discovery in Colorado. A major research goal of the CDD is to harness the diverse biology and disease models at CU AMC and throughout Colorado for HTS/HCS drug discovery. Recent funding of the CDD has led to the comprehensive drug discovery and development shared resource (D3SR) that is affiliated with the CDD and the CU Cancer Center. The D3SR features new custom equipment from PerkinElmer, including an Explorer G3 Workstation, Opera Phenix Plus HCS system, a Janus G3, EnVision multimode plate reader, and a custom BioSpot (Tek-Matic/BioFluidix).


Drexel University College of Medicine, US

Dr. Qiang has a strong background in the field of neurodegenerative disease research. He earned his MD and MS degrees from Nantong University in 2000 and 2003, respectively, before completing his PhD at Drexel University in 2009. His doctoral thesis, entitled “Functional Analyses of Microtubule Severing Proteins in the Central Nervous System,” showcased his extensive knowledge and expertise in the field. After completing his postdoctoral research at Columbia University Medical Center, where he conducted pivotal research on Alzheimer’s and Parkinson’s diseases, Dr. Qiang joined Angriocrine Bioscience in 2013 as a principal scientist. There, he played a vital role in establishing an in vitro platform of the blood-brain barrier for drug screenings in the central nervous system, as well as a CNS-derived microvasculature environment to support neuronal reprogramming.

Baobing Zhao

Shandong University, China

Zhao Baobing is a professor at the School of Pharmacy of Shandong University and a doctoral supervisor in pharmacology; a young expert of “Taishan Scholar” in Shandong Province and a Qilu Young Scholar of Shandong University. Graduated from Xiamen University with a Ph.D. in Biology. From 2012 to 2017, he studied abroad at Northwestern University in the United States for 5 years, serving as a postdoctoral researcher and research assistant professor. From May 2018 to present, he serves as a professor at the School of Pharmacy of Shandong University. He has long been committed to the discovery of active lead compounds and potential drug targets, focusing on the development of hematopoietic cells, revealing new mechanisms of regulation of blood cell development, elucidating the pathogenesis of malignant hematological diseases, and discovering potential drug targets. So far, he has published more than 40 SCI papers, of which he has published more than 30 SCI papers as the first or corresponding author in authoritative international academic journals such as Advanced Science, Journal of Clinical Investigation, Leukemia, Developmental Cell, Pharmacology & Therapeutics. In recent years, he has presided over 7 National Natural Science Foundation projects, provincial talent projects and other projects. He serves as a youth member of the Teaching and Science Popularization Committee of the Chinese Pharmacological Society, a director of the Shandong Provincial Pharmacological Society, a director of the Society of Cell Biology, a member of the Provincial Medical Association’s Cord Blood Clinical Application Multidisciplinary Joint Committee, a National Natural Science Foundation communication review expert, and a provincial industry and informatization expert. Registered expert with the Department; guest editor of SCI journal Front Cell Dev Biol, editorial board member of TMR-Pharm Research; reviewer of journals such as Molecular Cell, Advanced Science, Eur J Med Chem, and Blood Advances.

Nikolaos Trasanidis

Imperial College, UK

Dr. Nikolaos Trasanidis is an Honorary Research Fellow at the Centre for Haematology and the Hugh & Josseline Langmuir Centre for Myeloma Research. He received his PhD degree in cancer epigenomics from Imperial College London in 2020. He has a strong expertise in the application of high-throughput (“omics”) technologies in clinical research, including prognostic markers discovery, precision medicine, molecular diagnosis and targeted therapies development. His research interests focus on the development of systems medicine strategies to reveal the genetic and epigenetic alterations underlying multiple myeloma disease initiation and progression, for the discovery of novel molecular targets and personalized therapies.